Lasofoxifene
| CAS No. | 180916-16-9 | Cat. No. | BCP03626 |
| Name | Lasofoxifene | ||
| Synonyms | CP 336156; CP336156; CP-336156; CP 336,156; CP336,156; CP-33,6156; | ||
| Formula | C28H31NO2 | M. Wt | 413.55 |
| Description | Lasofoxifene, also known as CP 336156, is a non-steroidal selective estrogen receptor modulator (SERM) for the prevention and treatment of osteoporosis and for the treatment of vaginal atrophy. In September 2005, Pfizer received a non-approvable letter from the U.S. Food and Drug Administration regarding lasofoxifene (trade name Oporia), a selective estrogen receptor modulator for the prevention of osteoporosis. Lasofoxifene was approved in the EU under the brand name Fablyn by the EMEA in March 2009. Lasofoxifene is a desmethyl dihydro analog of nafoxidine. | ||
| Related Products | 190791-29-8（Lasofoxifene Tartrate） | ||
| Pathways | Hormone Pathay | ||
| Targets | Estrogen Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.